Abstract
AbstractEpstein-Barr virus is the first human virus related to human cancer and is currently associated with at least ten cancers mainly arisen from B or T lymphocytes or from epithelial cells. EBV-associated tumors are responsible for 1,8 % of all cancer-related deaths worldwide. The routinely detection in biopsy tissues of non coding RNA EBERs (EBv-Encoded small RNA) by in situ hybridization assay remains the hallmark of all EBV-associated malignancies. The EBV-associated cancers are also characterized by abnormal EBV DNA viral load in whole blood or plasma and atypical serological profiles (IgG/IgA against VCA, Viral Capsid Antigen ; EA Early Antigen ; EBNA1 Epstein-Barr Nuclear Antigen 1 ). The analysis of these virological biomarkers are recommended for the screening, diagnosis or the therapeutic follow up of patients at high risk of post transplant lymphoproliferative disease, patients with nasopharyngeal carcinoma and EBV associated T/NK lymphoma. Their clinical usefulness in Hodgkin lymphoma and gastric carcinoma is likely but less established.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
